← Open Payments lookup

CAROL KIMANI: Open Payments

NPI 1366153827 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$999 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $668 · 2025 $999

Food & beverage: $999
CompanyPaymentsAmount
Madrigal Pharmaceuticals3$169
Takeda Pharmaceuticals U.S.A., Inc.6$149
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$148
Phathom Pharmaceuticals, Inc.1$121
ABBVIE INC.4$95
Lilly USA, LLC3$82
Janssen Biotech, Inc.3$77
PFIZER INC.4$77
GENZYME CORPORATION1$29
Alnylam Pharmaceuticals Inc.1$18

Products named: REZDIFFRA, XIFAXAN, ENTYVIO, VOQUEZNA, OMVOH, TREMFYA, VELSIPITY, RINVOQ.

Industry payments across MD — which companies pay providers there.